Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MicroNO: Lung microbiota evolution after nitrous oxide in pediatric airway sampling
2024-518197-14-00Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Feb 2025
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of nitrous oxide + oxygen in bronchopulmonary diseases, pulmonary infection, bronchiolitis and 2 more (2 arms), sponsored by Centre Hospitalier Universitaire de Brest. Started Feb 2025; status: completed.
02
Drugs
nitrous oxide + oxygen
03
Conditions
bronchopulmonary diseasespulmonary infectionbronchiolitisasthmapneumonia
Beyond the preview
Go deeper on 2024-518197-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518197-14-00.